FDA issues new recommendations on feeding tube use
By
Marty Stempniak
Sep 12, 2018
Providers should take extra precautions when using feeding tubes, according to new guidance from the Food and Drug Administration.
FDA advisers vote ‘no’ on drug that may slow Alzheimer’s progression
By
Alicia Lasek
Nov 09, 2020
If approved by the FDA, aducanumab would be the first-ever drug marketed to slow progression of the brain-wasting disease, according to its developer. But an advisory committee was unconvinced of the drug’s...
Painkiller restrictions could hamper nursing home residents, providers
By
McKnight's Staff
Jan 29, 2013
Nursing home residents could be adversely affected if proposed painkiller regulations are put in place, according to experts who spoke at a recent federal hearing.
HHS extends coverage for COVID-19 screening at nursing homes
By
Danielle Brown
Sep 01, 2020
Nursing homes in states that prohibit the use of point-of-care COVID-19 tests to screen for the disease can now do so after the Department of Health and Human Services extended coverage to include congregate...
FDA proposes glucose meter guidance to improve infection control in nursing homes, hospitals
By
Tim Mullaney
Jan 09, 2014
The U.S. Food and Drug Administration has drafted more stringent guidelines for blood glucose monitoring test systems used in nursing homes, hospitals and other healthcare settings.
Long-term care advocates denounce FDA over new hydrocodone restrictions
By
Tim Mullaney
Oct 28, 2013
The U.S. Food and Drug Administration has announced it will seek restricted access to hydrocodone painkillers, prompting a concerned response from long-term care stakeholders.
FDA halts use of REGEN-COV, Eli Lilly monoclonal antibodies
By
Alicia Lasek
Jan 26, 2022
The Food and Drug Administration has revoked its emergency use authorizations for two monoclonal antibody cocktails that have served as COVID-19 treatment mainstays in long-term care facilities.
FDA approves extended-release opioid painkiller
By
Elizabeth Newman
Nov 21, 2014
The U.S. Food and Drug Administration gave market clearance to an extended-release opioid painkiller yesterday. It is designed for those with severe pain.
FDA panel approves first biosimilar drug
Mar 10, 2015
The Food and Drug Administration approved its first biosimilar product last week, opening the door for more costly drug alternatives.
Novavax applies for FDA authorization of its protein-based COVID shot
By
Amy Novotney
Feb 02, 2022
Biotech firm Novavax disclosed Monday that it had submitted its long-awaited application to the U.S. Food and Drug Administration for an emergency use authorization for its COVID-19 vaccine in the United...